SRx Health Solutions
Canada · Biotechnology, Health Care, Information Technology
SRx Health Solutions operates as a Canadian healthcare service provider specializing in the Specialty Pharmacy segment of the pharmaceutical industry. It is distinguished as a National Specialty Pharmacy provider, concentrating on overseeing a patient's healthcare journey, spanning from acute pharmaceutical needs to chronic and rare disease management. Their offerings include wholesale/distributio
Key facts
- Headquarters
- Canada
- Employees
- 218
- Industries
- Biotechnology, Health Care, Information Technology
- Status
- Public (SRXH)
- Website
- srxhealth.com
- Company page
Recent activity at SRx Health Solutions
- : SEC 8-K (1.01): On September 8, 2026, SRX Global Inc. entered into a Limited Consent and Amendment Agreement with certain accredited investors relating to a previously disclosed Securities Purchase Agreement from August 27, 2026. Under the terms of the Securities Purchase Agreement, the investors purchased 3,579 shares of Series C convertible preferred stock for an aggregate purchase price of $2.825 million, which can be converted into common stock. The Consent Agreement further details modifications or consents necessary from the required holders regarding the initial purchase agreement. This transaction enhances the Company’s capital structure and provides flexibility for future funding processes.
- : SEC 8-K (1.01): On August 31, 2026, SRX Global Inc. entered into a material definitive agreement with CERo Therapeutics Holdings, Inc. involving a secured financing transaction. This culminated in the issuance of a Consolidated Senior Secured Promissory Note by CERO to SRX Global, which has an original issue date of August 27, 2026. This Note consolidates previous outstanding convertible grid promissory notes from CERO totaling $5,666,108.77, and enables further advances up to $6,000,000, offering significant strategic financial leverage to SRX Global. The transaction reflects CERO's ongoing financial engagements following the consolidation of earlier obligations.
- : SEC 8-K (1.01): On August 27, 2026, SRX Global Inc. entered into a Securities Purchase Agreement with certain accredited investors, selling 3,579 shares of Series C convertible preferred stock for $2,862,500. The purchase price was satisfied by the assignment of Convertible Grid Promissory Notes from CERO Therapeutics Holdings, Inc., totaling an original principal amount of $2,812,500. This transaction enables SRX Global Inc. to leverage the convertible notes for immediate capital, enhancing its financial position and potential growth prospects.
- : SRx Health Solutions merges with EMJ Crypto Technologies
- : SEC 8-K (5.02): On November 10, 2025, SRx Health Solutions, Inc. appointed Sammy Dorf, Esq. as a director of the Company, effective immediately. Mr. Dorf will serve until his successor is elected or he resigns or is removed. He currently serves as the Executive Chairman of Flora Growth Corp. and previously co-founded Verano Holdings, a successful multi-state cannabis company. This appointment is expected to bring significant industry expertise and leadership to SRx Health Solutions.
- : SEC 8-K (1.01): On October 27, 2025, SRx Health Solutions, Inc. entered into a Securities Purchase Agreement with accredited investors for the sale of up to 38,070 shares of Series A convertible preferred stock and accompanying warrants to purchase the Company’s common stock. The agreement allows for these securities to be purchased for an aggregate purchase price, reflecting a strategic move to raise capital. This transaction is expected to enhance the Company’s financial position and support its operational objectives moving forward.
- : SRx Health Solutions Appoints Adesh Vora as Chief Executive Officer and Nina Martinez as Chief Financial Officer
- : Better Choice Co Inc.
- : Better Choice Co Inc.
- : Better Choice Co Inc.
SRx Health Solutions funding history
| Date | Round | Amount |
|---|---|---|
| Feb 2021 | Seed | $4.1M |
| Oct 2020 | Venture | $18.9M |
| Jun 2020 | Seed | $1.5M |
| Jan 2020 | Venture | $23.5M |
| May 2019 | Venture | $108.0M |
Leadership
- Michael Close, Director
- Damian Dalla-Longa, Director
- Jeff Davis, Director
- Clinton Gee, Director
- Lori Taylor, Director
- John III, Director
- Michael Young, Director
- Werner Pein, Executive Officer, Director
- Damian Dalla-Longa, Director
- Jeff Davis, Director
- Clinton Gee, Director
- Lori Taylor, Director
Verified email and direct lines for SRx Health Solutions’s decision-makers are on Fundz. See plans
SRx Health Solutions in the news
- SRx Health Solutions Obtains Initial Order under CCAA for its Canadian Subsidiary - Yahoo Finance (Aug 12, 2025)
- SRx Health Solutions Announces Fiscal Second Quarter 2026 Results for Quarter Ended March 31, 2026 - GlobeNewswire (May 14, 2026)
- SRx Health Solutions Announces the Cancellation of Approximately 18.8 Million Shares of its Capital Stock - Yahoo Finance (Aug 14, 2025)
- SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences - GlobeNewswire (Jun 23, 2026)
- SRx Health Solutions Granted Final Order to Proceed with the Acquisition by Better Choice Company - Yahoo Finance (Feb 28, 2025)
- SRx Health Solutions, Inc. (formerly known as Better Choice - GlobeNewswire (Apr 25, 2025)
- Better Choice Company Chairman Provides Shareholder Update on SRx Health Acquisition and Comments on Recent Debt-to-Equity Transaction - Yahoo Finance (Apr 04, 2025)
- Better Choice Company Signs Definitive Agreement to Acquire SRx Health for Approximately $125 Million - GlobeNewswire (Sep 03, 2024)
Companies similar to SRx Health Solutions
- Tilray Medical · Biotechnology, Health Care, Information Technology, Medical, Other
- GE HealthCare · Biotechnology, Health Care, Information Technology, Medical, Other
- Nusano · Biotechnology, Health Care, Information Technology, Medical
- Parol · Biotechnology, Health Care, Information Technology, Medical
- Tasso · Biotechnology, Health Care, Information Technology, Other
About SRx Health Solutions: questions and answers
What does SRx Health Solutions do?
SRx Health Solutions operates as a Canadian healthcare service provider specializing in the Specialty Pharmacy segment of the pharmaceutical industry. It is distinguished as a National Specialty Pharmacy provider, concentrating on overseeing a patient's healthcare journey, spanning from acute pharmaceutical needs to chronic and rare disease management. Their offerings include wholesale/distributio
Where is SRx Health Solutions headquartered?
SRx Health Solutions is headquartered in Canada.
How many employees does SRx Health Solutions have?
SRx Health Solutions has about 218 employees.
Has SRx Health Solutions raised funding?
Yes. Fundz has recorded 5 funding events for SRx Health Solutions. The most recent, Seed of $4.1M, was in Feb 2021.
What is the latest news on SRx Health Solutions?
On Sep 08, 2026, SEC 8-K (1.01): On September 8, 2026, SRX Global Inc. entered into a Limited Consent and Amendment Agreement with certain accredited investors relating to a previously disclosed Securities Purchase Agreement from August 27, 2026. Under the terms of the Securities Purchase Agreement, the investors pu
Is SRx Health Solutions a public company?
Yes. SRx Health Solutions is publicly traded under the ticker SRXH.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy